-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Lifecore Biomedical, Raises Price Target to $6.5

Benzinga·06/16/2026 12:27:06
Listen to the news
Barrington Research analyst Michael Petusky maintains Lifecore Biomedical (NASDAQ:LFCR) with a Outperform and raises the price target from $6 to $6.5.